Germany-based molecular cartography technology company
Resolve Biosciences has raised €72M across 1 funding round from 5 investors, most recently a Series B round in Oct 2022. Based in Munich, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-10-24 | Series B |
| €72M |
| Alafi Capital,EDBI,NRW.BANK,Patient Square Capital,PS Capital |
| View deal → |
